Advice
Following an abbreviated submission
donepezil orodispersible tablet (Aricept Evess®) is accepted for use within NHS Scotland for the symptomatic treatment of mild to moderately severe Alzheimer’s dementia in patients for whom donepezil is appropriate and who have difficulty in swallowing solid oral dose formulations. It costs the same as standard formulations of donepezil.
Download detailed advice21KB (PDF)
Medicine details
- Medicine name:
- donepezil 5mg & 10mg orodispersible tablets (Aricept Evess)
- SMC ID:
- 307/06
- Indication:
- Mild to moderately severe Alzheimer's dementia
- Pharmaceutical company
- Eisai Ltd
- BNF chapter
- Central nervous system
- Submission type
- Abbreviated
- Status
- Superseded
- Date advice published
- 26 February 2007